February 3, 2021
During The PSYCH Symposium in November 2020, a panel of leading experts,operating in psychedelics sector discussed the advancement of research
January 20, 2021
During The PSYCH Symposium in November 2020, Professor David Nutt, chairman of Awakn Life Sciences, founder of Drug Science and the
December 2, 2020
A new company straddling both the functional health and psychedelic space with a consumer/retail first approach. Backed by a leading
October 29, 2020
Exclusive: Saint Vincent and the Grenadines announces initiative to permit psychedelic treatment and research The Caribbean nation of Saint Vincent
October 21, 2020
For the first time, stock in a psychedelic medicine company was traded on the market – and it was major
October 21, 2020
Field Trip Health Ltd. (CSE: FTRP) began trading shares on the Canadian Securities Exchange on Tuesday 6th October, opening at $3.50
September 3, 2020
While a number of states have begun to legalise the medical use of certain psychedelics, widespread legalisation is set to start
August 19, 2020
This is a nascent and fast emerging industry, witnessing a flurry of commercial activity, including the founding of new companies,
August 5, 2020
PSYCH by Prohibition Partners conducts proprietary research on consumer attitudes to psychedelics In May 2020, Prohibition Partners conducted a nationally
